(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
503A Bulks List Prepares for Five Potential New Additions

503A Bulks List Prepares for Five Potential New Additions

by Jennifer P | Sep 25, 2019 | Uncategorized

The U.S. Food and Drug Administration (FDA) has officially released a proposed rule to amend the list of bulk drug substances that can be used to compound drug products with the addition of five new substances to the list. If approved, glutaraldehyde, glycolic acid,...
Update on Titanium Dioxide in Sunscreens

Update on Titanium Dioxide in Sunscreens

by Jennifer P | Sep 12, 2019 | Canadian Regulatory, Cosmetics, Research/Science/Technology, U.S. Regulatory, Uncategorized

Currently, the Canadian Natural Health Products Ingredients Database (NHPID) lists Titanium dioxide (TiO2) as an opacifying agent and color additive for topical use, but is NOT permitted in sunscreens for these uses. However, according to Cosmetics Alliance Canada,...
Microbeads in Toiletries Regulations

Microbeads in Toiletries Regulations

by Jennifer P | Sep 4, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology

On July 1st, 2019, the full Canadian prohibition on Microbeads in Toiletries came into effect for cosmetic products as well as natural and non-prescription products. As a result, regulatory officials may be kickstarting an enforcement program to ensure companies are...

Recent Posts

  • FDA OTC MONOGRAPH DRUG USER FEE RATES FOR FISCAL YEAR 2021
  • Phase I of the Self-Care Framework
  • Changes to INCI Names for Hydrocarbons
  • Health Canada Risk Evaluation of N-nitrosamine Impurities: First Step Deadline Fast Approaching
  • Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (IO No. 2)

Recent Comments

    Archives

    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Importation of NHPs
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2021 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY